Microwave Treatment for Actinic Keratosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates a new microwave treatment using the Swift System to address Actinic Keratosis (AK), a skin condition that can lead to cancer. The researchers aim to assess the treatment's effectiveness by comparing treated and untreated AK spots on the same person. Participants must have 10, 12, or 14 small AK lesions (pre-cancerous skin patches) on their scalp or hands. Those with these conditions who are willing to pause any current treatments for AK may be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to pioneering research that could lead to new treatment options for AK.
Will I have to stop taking my current medications?
If you are currently receiving treatment for Actinic Keratosis, you will need to stop your medication for at least 28 days before starting the study treatment. You also need to avoid using any other Actinic Keratosis products or treatments during the study.
What prior data suggests that this microwave treatment is safe for actinic keratosis?
Research has shown that microwave therapy, such as the Swift System, is generally safe and well-tolerated for treating actinic keratosis (AK). Studies have found this therapy easy to use and acceptable for treating AK, making it a promising option to prevent the condition from worsening. Reports indicate that this therapy is both safe and effective.
Although specific data on side effects for this treatment is limited, using microwave therapy for similar skin conditions suggests it is likely well-tolerated. The treatment involves short bursts of microwave energy applied directly to the affected area, so any discomfort is usually brief.
Overall, while more data would be helpful, existing studies suggest that the Swift System is a safe option for treating AK.12345Why are researchers excited about this trial?
Microwave treatment with the Swift System is unique because it uses microwave energy to target actinic keratosis lesions directly. Unlike traditional treatments like topical creams or cryotherapy, which can take time to show results, this method delivers a quick burst of energy directly to the lesion, potentially offering faster and more precise results. Researchers are excited about its non-invasive approach and the possibility of fewer side effects, making it a promising alternative for managing actinic keratosis.
What evidence suggests that the Swift System is effective for Actinic Keratosis?
Research has shown that the Swift System, a microwave treatment, may effectively treat Actinic Keratosis (AK), a skin condition. One study found that 90% of AK spots disappeared 120 days after the microwave treatment. Remarkably, 78% of spots cleared up just one week after treatment. This trial will evaluate the effectiveness of the Swift System, with participants receiving microwave treatment applied locally to each AK lesion. The early results are promising, making it a potential option for people with AK.12367
Who Is on the Research Team?
Professor Dirschka
Principal Investigator
CentroDerm GmbH, Heinz-Fangman-Strasse 57, 42287 Wuppertal (Barmen), Germany
Dr Waibel
Principal Investigator
Miami Dermatology and Laser Institute, Miami, Florida, United States, 33173
Are You a Good Fit for This Trial?
This trial is for adults with Actinic Keratosis lesions on their scalp or hands. Participants must have an even number of lesions (10, 12, or 14) and agree not to use other AK treatments during the study. Exclusions include pregnancy, breastfeeding, recent participation in another trial, certain medical conditions like skin cancer history or immunosuppression, and metal implants at treatment sites.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Swift Microwave Treatment for Actinic Keratosis lesions, with up to 2 treatments spaced by a 4-week interval
Follow-up
Participants are monitored for resolution or recurrence of AK lesions at 2, 4, 6, and 12 months post first treatment
What Are the Treatments Tested in This Trial?
Interventions
- Swift System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Blackwell Device Consulting
Lead Sponsor
Emblation Limited
Industry Sponsor